Remove latest
article thumbnail

Healthee heads latest crop of digital health financings

pharmaphorum

Our latest round-up of funding rounds in the digital health category features updates from Healthee, Aktiia, Moxe Health, Eleanor Health, Tava Health, BrainCheck, and Redi Health.

105
105
article thumbnail

e-therapeutics is latest UK biotech to seek AIM de-listing

pharmaphorum

e-therapeutics is the latest UK biotech to say it plans to delist from the AIM, citing a lack of interest from institutional investors.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Synnovation’s $102m round heads latest biotech financings

pharmaphorum

Our latest crop of biotech financings features rounds for Synnovation Therapeutics and Adicet Bio, Calluna Pharma, Accent Therapeutics, GenEdit and IMU Bio

106
106
article thumbnail

STAT+: ‘Devalued, disempowered, and unseen’: Mass General Brigham doctors react to latest merger step

STAT

Mass General Brigham, a dominant force in Boston medicine, was launching the latest and perhaps most contentious step in its ongoing effort to merge its two flagship Harvard-affiliated medical centers: combine all departments and divisions at both hospitals in a move that executives argued would improve patient care and access.

Hospitals 117
article thumbnail

Opinion: What the public might learn from Kate Middleton, the latest ‘famous patient’

STAT

The latest entry is that of Catherine, the Princess of Wales, also known as Kate Middleton, who revealed she has cancer and is undergoing chemotherapy. As with her many of her predecessors, the princess’s story will likely both reveal and conceal, but I suspect it will ultimately both move and enlighten the public.

article thumbnail

Highlights: What Pharmacists Need to Know about ACIP’s Latest 2023 Vaccination Schedule Updates

Drug Topics

Keep your pharmacy services up to date with the latest 2023 ACIP vaccination schedule updates and recommendations.

Vaccines 200
article thumbnail

Myth vs. Fact: The Senate’s latest price setting proposal

PhRMA

The narratives being built around the Senate’s latest price setting proposal frame it as a bill intended to lower drug prices for patients and address rising inflation. But those narratives aren’t the facts. Here, we bust those myths.

130
130